The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications
Open Access
- 12 January 2023
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (5) , 629-635
Abstract
No abstract availableKeywords
Funding Information
- Foundation for Barnes-Jewish Hospital
This publication has 50 references indexed in Scilit:
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 InfectionNew England Journal of Medicine, 2015
- Transplanting Hepatitis C–Positive KidneysNew England Journal of Medicine, 2015
- Big Data in Organ Transplantation: Registries and Administrative ClaimsAmerican Journal of Transplantation, 2014
- Doubly Robust Estimation of Causal EffectsAmerican Journal of Epidemiology, 2011
- Underutilization of Hepatitis C-Positive Kidneys for Hepatitis C-Positive RecipientsAmerican Journal of Transplantation, 2010
- A Comprehensive Risk Quantification Score for Deceased Donor Kidneys: The Kidney Donor Risk IndexTransplantation, 2009
- Constructing Inverse Probability Weights for Marginal Structural ModelsAmerican Journal of Epidemiology, 2008
- Transplant data: sources, collection and research considerations, 2004American Journal of Transplantation, 2005
- The Impact of Transplantation with Deceased Donor Hepatitis C-Positive Kidneys on Survival in Wait-Listed Long-term Dialysis PatientsAmerican Journal of Transplantation, 2004
- Prevalence of Hepatitis C Virus RNA in Organ Donors Positive for Hepatitis C Antibody and in the Recipients of Their OrgansNew England Journal of Medicine, 1992